167 related articles for article (PubMed ID: 17662008)
1. Copaxone interferes with the PrP Sc-GAG interaction.
Engelstein R; Ovadia H; Gabizon R
Eur J Neurol; 2007 Aug; 14(8):877-84. PubMed ID: 17662008
[TBL] [Abstract][Full Text] [Related]
2. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
3. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression.
Hijazi N; Kariv-Inbal Z; Gasset M; Gabizon R
J Biol Chem; 2005 Apr; 280(17):17057-61. PubMed ID: 15668233
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide delays PrP sc accumulation and disease symptoms in prion-infected hamsters.
Shaked GM; Engelstein R; Avraham I; Kahana E; Gabizon R
Brain Res; 2003 Sep; 983(1-2):137-43. PubMed ID: 12914974
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
6. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of P53-related apoptosis had no effect on PrP(Sc) accumulation and prion disease incubation time.
Engelstein R; Grigoriadis N; Greig NH; Ovadia H; Gabizon R
Neurobiol Dis; 2005 Mar; 18(2):282-5. PubMed ID: 15686956
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
9. Tetracyclines affect prion infectivity.
Forloni G; Iussich S; Awan T; Colombo L; Angeretti N; Girola L; Bertani I; Poli G; Caramelli M; Grazia Bruzzone M; Farina L; Limido L; Rossi G; Giaccone G; Ironside JW; Bugiani O; Salmona M; Tagliavini F
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10849-54. PubMed ID: 12149459
[TBL] [Abstract][Full Text] [Related]
10. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
11. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
[TBL] [Abstract][Full Text] [Related]
12. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.
Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA
Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653
[TBL] [Abstract][Full Text] [Related]
13. Copper binding to PrPC may inhibit prion disease propagation.
Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
15. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
[TBL] [Abstract][Full Text] [Related]
17. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
18. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
19. Antiprion properties of prion protein-derived cell-penetrating peptides.
Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
[TBL] [Abstract][Full Text] [Related]
20. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]